Background. Sentinel node (SN) biopsy has been tried in the management of a
va variety of cancers with the hope that it would eliminate many unnecessa
ry lymph node dissections, resulting in less morbidity. This important tech
nique, however has not been tried in gastric cancer surgery. The feasibilit
y of SN biopsy and its accuracy in predicting the lymph node status in pati
ents with gastric cancer were examined in the current study.
Patients and methods. SN biopsy was performed in patients with T1 (n = 44)
or T2 (n = 30) gastric cancers (ie, immediately after laparotomy, indocyani
ne green was injected around the primary tumor and the green-stained nodes
[SNs: 2.6 +/- 1.7 nodes per patient] were removed). Then, gastrectomy with
extended lymphadenectomy was performed. The unstained nodes (non-SNs: 39 +/
- 18 nodes per-patient) were obtained from the resected specimens. Both SNs
and non-SNs were subjected to histologic examination with hematoxylin-eosi
n.
Results. SNs could be identified in 73 of 74 patients (success rate, 99%).
Of these 73 patients, 10 had lymph node metastases in SNs or non-SNs, or bo
th; 6 in both SNs and non-SNs; 3 in SNs alone; and 1 in non-SNs alone. The
sensitivity of the SN status in the diagnosis of the lymph node status of t
he patient was 90% (9/10) and specificity was 100% (63/63). Sensitivity was
100% in the n group (n = 44) and 88 % in the T2 group (n = 23).
Conclusions. SN biopsy using indocyanine green can be performed with a high
success rate, and the SN status can predict the lymph node status with a h
igh degree of accuracy especially in patients with T1 gastric cancer.